Haleon UK Export Limited
Wholesale of pharmaceutical goods · Weybridge
ActiveUnited KingdomIncorporated 2020Private Limited Company
Financial position
Accounts to 2025-12-31 · GBP · Company accounts
Net assets
£22,977,000
Cash
£1,139,000
Turnover
£267,049,000
Profit / loss
£1,134,000
Current assets
£128,113,000
Creditors < 1 year
£101,335,000
Equity
£22,977,000
Average employees
Not available
Balance-sheet trend
GBP · companyFinancial statements
Selected figures from the best-ranked available filing for each period. Missing values remain unknown.
Some figures were read by AI from scanned accounts, so small errors are possible. View the filed accounts
| Reported figures | 2025-12-3112 months · Company · AI-read | 2024-12-31Company · AI-read |
|---|---|---|
| Balance sheet | ||
| Net assets | £22,977,000 | £21,368,000 |
| Equity | £22,977,000 | £21,368,000 |
| Retained earnings | £24,725,000 | £24,798,000 |
| Assets | ||
| Fixed assets | £3,411,000 | £4,880,000 |
| Intangible assets | £2,112,000 | £2,234,000 |
| Property, plant & equipment | £65,000 | £141,000 |
| Current assets | £128,113,000 | £164,562,000 |
| Cash at bank | £1,139,000 | £785,000 |
| Debtors | £93,962,000 | £122,308,000 |
| Stock | £32,512,000 | £41,469,000 |
| Liabilities | ||
| Creditors | £108,547,000 | £148,074,000 |
| Creditors within one year | £101,335,000 | £139,510,000 |
| Creditors after one year | £7,212,000 | £8,564,000 |
| Net current assets | £26,778,000 | £25,052,000 |
| Assets less current liabilities | £30,189,000 | £29,932,000 |
| Profit & loss | ||
| Turnover | £267,049,000 | £281,682,000 |
| Cost of sales | £184,234,000 | £196,235,000 |
| Gross profit | £82,815,000 | £85,447,000 |
| Distribution costs | £55,843,000 | £57,946,000 |
| Administrative expenses | £17,267,000 | £16,016,000 |
| Other operating income | −£2,885,000 | £150,000 |
| Operating profit | £3,896,000 | £8,721,000 |
| Interest receivable | £435,000 | £1,807,000 |
| Interest payable | £2,574,000 | £4,512,000 |
| Profit before tax | £1,757,000 | £6,016,000 |
| Tax | £623,000 | £396,000 |
| Profit / loss | £1,134,000 | £5,620,000 |
| Operating costs | ||
| Depreciation | £65,000 | £70,000 |
| Amortisation | £400,000 | £453,000 |
| People & pay | ||
| Staff costs | £27,715,000 | £23,915,000 |
| Wages & salaries | £26,172,000 | £22,829,000 |
| Social security costs | £654,000 | £669,000 |
| Pension costs | £59,000 | £54,000 |
| Source evidence | View filing | View filing |
From the accounts
What the accounts for 2025-12-31 say about themselves, read by AI from the scanned filing.
- Principal activity
- The principal activity of the Company is the distribution of consumer healthcare products purchased from the Group to third parties in territories where the Group does not have a legal presence. The Company also provides business support services to other Group entities and performs limited sales and marketing functions in support of its distribution activities.
- What it does
- consumer healthcare products · distribution · business support services · sales and marketing · third parties (AI keywords)
- The year
- The Company made a profit for the financial year of £1,134k (2024: £5,620k). The decrease in profit compared with the prior year was primarily driven by a reduction in operating profit.
- Outlook
- The Directors do not envisage any change to the nature of the business in the foreseeable future.
- Auditor
- KPMG LLP · senior statutory auditor Robert Araeb
- Audit opinion
- Clean (unmodified)
- Immediate parent
- Haleon UK Enterprises Limited
- Ultimate parent
- Haleon plc · United Kingdom (England and Wales)
- Ultimate controlling party
- Haleon plc
- Accounts
- FRS 101
- Approved
- 2026-08-19, signed by Haider Adam Claude Hatteea
Turnover by segment (4)
- United Kingdom: 13,843 (000s) (2025-12-31)
- United Kingdom: 13,593 (000s) (2024-12-31)
- Rest of World: 253,206 (000s) (2025-12-31)
- Rest of World: 268,089 (000s) (2024-12-31)
Directors' report (6)
- Haider Adam Claude Hatteea
- Jonathan Paul Preece · resigned 2025-04-25
- Arshad Baig
- Haleon UK Corporate Secretary Limited
- Haleon UK Corporate Director Limited
- Ana Maria Teaca · resigned 2025-03-25
Contingent liabilities (1)
- The Company, together with fellow Group undertakings, has entered into a Group banking arrangement with the Company's principal bank. The bank holds the right to pay and apply funds from any account of the Company to settle any indebtedness to the bank of any other party to this agreement. The Company's maximum potential liability as at 31 December 2025 is limited to the amount held on its accounts with the bank. No loss is expected to accrue to the Company from the agreement.
Secured borrowing
Registered charges, lenders and security interests.
Charges and related records
0 outstanding chargesNo charges available in our records.